Hormonal
Tirzepatide produces significantly greater monthly and annual weight loss, higher patient satisfaction, and improved quality of life compared to Semaglutide and Liraglutide in a Kuwaiti population.
If you are considering GLP-1 therapy for weight loss in Kuwait, Tirzepatide appears to offer the highest weight loss and satisfaction rates compared to Semaglutide and Liraglutide. Be aware that side effects like belching (Tirzepatide) or anxiety (Liraglutide) may influence your choice, and check government facility availability to manage costs.
Tirzepatide users (N = 132; 27.8%) reported significantly higher monthly and annual weight-loss (4.76 ± 2.82 kg/month; 8.48 ± 4.04 kg/year), and greater satisfaction (88%) and improved quality of life (60%) compared to both Semaglutide (N = 181; 37.2%) and Liraglutide (N = 152; 31.3%), respectively.
Why this rating
Cross-sectional survey design with self-reported data introduces recall bias and lacks controlled dosing verification, though the sample size is large.
Source
A comparison of Glucagon-like peptide-1 receptor agonists on weight change, side effects, and quality of life in Kuwait
Saad Al‐Ali et al. · Frontiers in Nutrition · 2025
DOI 10.3389/fnut.2025.1590379
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →